NIO
NIO Inc.
NIO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
SRI
Stoneridge, Inc.
There isn't enough reported data to score SRI yet.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
SRI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
SRI's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
SRI PE Valuation
SRI has no meaningful PE right now: it lost money over the past year.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
SRI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| -- | |
| Limited | |
| -- |
Analysts expect SRI's earnings to decline, with its revenue and profitability holding steady.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO has the edge over SRI on earnings, with more consistent year-over-year improvement.
SRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$4.76 | -$3.60 |
| Q2 2026 | -$4.29 | -$3.21 |
| Q1 2026 | -$4.44 | -$3.80 |
| Q4 2025 | -$3.70 | -$3.10 |
| Q3 2025 | -$1.16 | -$0.89 |
| Q2 2025 | -$1.08 | -1643% |
| Q1 2025 | -$0.64 | -$0.50 |
| Q4 2024 | -$0.60 | -$0.41 |
SRI lost $4.76 per share over the past year, a bigger loss than the year before.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over SRI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO has the edge over SRI on profitability, with a higher operating margin.
SRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $155.8M | -26% |
| Q2 2026 | $181.4M | -20% |
| Q1 2026 | $160.8M | -26% |
| Q4 2025 | $205.2M | -6% |
| Q3 2025 | $210.3M | -1.7% |
| Q2 2025 | $228M | -3.8% |
| Q1 2025 | $217.9M | -8.9% |
| Q4 2024 | $218.2M | -4.9% |
SRI's revenue has slid since its 2023 peak: $156M last quarter, down 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -15% | -14 points |
| Q2 2026 | -0.7% | +0.5 points |
| Q1 2026 | -5.6% | -4.1 points |
| Q4 2025 | -14% | -12 points |
| Q3 2025 | -1.6% | -1.7 points |
| Q2 2025 | -1.1% | -2.6 points |
| Q1 2025 | -1.5% | -1.6 points |
| Q4 2024 | -2% | -4.7 points |
SRI's operating margin was −15% last quarter, down 14 points from the same quarter a year ago, near the bottom of its range since 2019.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
SRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$236K | +$2.5M |
| Q2 2026 | $7.7M | +4.5% |
| Q1 2026 | -$12.3M | -356% |
| Q4 2025 | $2.6M | -81% |
| Q3 2025 | -$2.7M | -158% |
| Q2 2025 | $7.4M | +385% |
| Q1 2025 | $4.8M | +46% |
| Q4 2024 | $14M | +1897% |
SRI has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has 2.5B diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
SRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +143K shares |
| 1 year | +1.9% | +528K shares |
| 3 years | +2.4% | +653K shares |
| 5 years | +4.6% | +1.2M shares |
| Available history | +0.4% | +117K shares |
SRI has the edge over NIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $5M |
| Q4 2019 | — |
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.8x | Net Cash |
| Q2 2025 | 5.2x | High |
| Q1 2025 | 4.3x | High |
| Q4 2024 | -2.1x | Net Cash |
| Q3 2024 | -1.2x | Net Cash |
| Q2 2024 | -0.8x | Net Cash |
| Q1 2024 | -0.9x | Net Cash |
| Q4 2023 | -0.8x | Net Cash |
SRI has more cash than debt.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
SRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.1 | Neutral |
| Stochastic | 9.0 | Oversold |
SRI's weekly RSI is 33 (neutral) and its Stochastic is 9 (oversold).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
SRI PE vs Consumer Cyclical Sector
| Metric | SRI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
SRI has no meaningful PE right now: it lost money over the past year.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
SRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.92 | 14% below |
| 20 week MA | $6.68 | 24% below |
| 50 week MA | $6.70 | 24% below |
| 100 week MA | $6.37 | 20% below |
| 200 week MA | $11.5 | 56% below |
SRI is in a downtrend: it's below all five of its weekly moving averages, and 56% below its 200-week average.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.
SRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.7 | $29.6 | -0.1% |
| 2021 | $29.6 | $18.7 | -37% |
| 2022 | $18.7 | $21.3 | +14% |
| 2023 | $21.3 | $19.6 | -8% |
| 2024 | $19.6 | $6.21 | -68% |
| 2025 | $6.21 | $5.69 | -8.4% |
| 2026 YTD | $5.69 | $5.09 | -11% |
SRI has the edge over NIO on returns for 2026, with the stronger performance.